Who Paid My Doc
Pvp-Ic1901
Research payments
$1,124,982
Through program year 2022, $1,124,982 in research payments was reported against Pvp-Ic1901, across 69 payments, paid by Provepharm Inc..
- Paid by
- Provepharm Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $98,044 | 11 |
| 2021 | Research | $561,232 | 25 |
| 2020 | Research | $402,867 | 27 |
| 2019 | Research | $62,840 | 6 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Steven Robison Idaho Falls, ID Named on 5 payments
- Mark White Albany, NY Named on 4 payments
- Kalpesh Patel Tucson, AZ Named on 4 payments
- David Bolster Summerville, SC Named on 4 payments
- Rebecca McCrery Omaha, NE Named on 4 payments
- James Rice Covington, WA Named on 3 payments
- Robert Jeanfreau Metairie, LA Named on 2 payments
- Keith Vrbicky Norfolk, NE Named on 2 payments
- Charles Pollack Roswell, GA Named on 2 payments
- Lucas Wiegand Tampa, FL Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.